Recombinant adeno-associated viral vector reference standards

Methods in Enzymology

Volumn 507, Issue , 2012, Pages 297-311

  Moullier, Philippe ^a,b,c   Snyder, Richard O ^a,b,d  

^a HÔTEL DIEU   (France)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c GÉNÉTHON   (France)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Adeno associated virus; Characterization; Gene transfer; Quality control; Reference standard; Safety

Indexed keywords

ENDOTOXIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; BIOTECHNOLOGICAL PROCEDURES; DRUG PURITY; DRUG QUALITY; DRUG STABILITY; DRUG STERILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GOOD MANUFACTURING PRACTICE; HUMAN; MYCOPLASMA; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; PROTEIN DETERMINATION; SEROTYPE; STANDARD; TRANSGENE; VIRION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS;

EID: 84857582187     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386509-0.00015-6     Document Type: Chapter

References (48)

1. J.A. Allay Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial Hum. Gene Ther. 22 2011 595 604
2. J.W. Bainbridge Effect of gene therapy on visual function in Leber's congenital amaurosis N. Engl. J. Med. 358 2008 2231 2239 (Pubitemid 351724452)
3. M.L. Brantly Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy Proc. Natl. Acad. Sci. USA 106 2009 16363 16368
4. C. Burger Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system Mol. Ther. 10 2004 302 317 (Pubitemid 39117875)
5. I.H. Carmen A death in the laboratory: The politics of the Gelsinger aftermath Mol. Ther. 3 2001 425 428 (Pubitemid 32509834)
6. G. Chadeuf Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome J. Gene Med. 2 2000 260 268 (In process citation)
7. A.V. Cideciyan Human RPE65 gene therapy for Leber congenital amaurosis: Persistence of early visual improvements and safety at 1 year Hum. Gene Ther. 20 2009 999 1004
8. K.R. Clark, F. Voulgaropoulou, and P.R. Johnson A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors Gene Ther. 3 1996 1124 1132
9. K.R. Clark, X. Liu, J.P. McGrath, and P.R. Johnson Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses Hum. Gene Ther. 10 1999 1031 1039 (Pubitemid 29195432)
10. R.G. Crystal Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis Hum. Gene Ther. 15 2004 1131 1154 (Pubitemid 39552294)
11. A. Donsante AAV vector integration sites in mouse hepatocellular carcinoma Science 317 2007 477 (Pubitemid 47196106)
12. L. Drittanti, C. Rivet, P. Manceau, O. Danos, and M. Vega High throughput production, screening and analysis of adeno-associated viral vectors Gene Ther. 7 2000 924 929 (Pubitemid 30386656)
13. M.J. During, M.G. Kaplitt, M.B. Stern, and D. Eidelberg Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation Hum. Gene Ther. 12 2001 1589 1591
14. T.R. Flotte, P. Burd, and R.O. Snyder Utility of a recombinant adeno-associated viral vector reference standard Bioprocessing 1 2002 75 77
15. T.R. Flotte Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study Hum. Gene Ther. 14 2003 1079 1088 (Pubitemid 36851399)
16. T.R. Flotte Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults Hum. Gene Ther. 15 2004 93 128 (Pubitemid 38147192)
17. G.P. Gao, M.R. Alvira, L. Wang, R. Calcedo, J. Johnston, and J.M. Wilson Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proc. Natl. Acad. Sci. USA 99 2002 11854 11859 (Pubitemid 34994488)
18. Gene Therapy Clinical Trials Worldwide. June 2011 Update. J. Gene Med. http://www.wiley.co.uk/genmed/clinical/
19. D. Grimm, A. Kern, M. Pawlita, F. Ferrari, R. Samulski, and J. Kleinschmidt Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2 Gene Ther. 6 1999 1322 1330 (Pubitemid 29359028)
20. D. Grimm, M.A. Kay, and J.A. Kleinschmidt Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6 Mol. Ther. 7 2003 839 850 (Pubitemid 36790261)
21. K.A. High Update on progress and hurdles in novel genetic therapies for hemophilia Hematol. Am. Soc. Hematol. Educ. Program 2007 2007 466 472
22. B. Hutchins Development of a reference material for characterizing adenovirus vectors Bioprocessing 1 2002 25 28
23. B. Hutchins Working toward an adenoviral vector testing standard Mol. Ther. 2 2000 532 534
24. C. Janson Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain Hum. Gene Ther. 13 2002 1391 1412 (Pubitemid 35034518)
25. A. Leger Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle PLoS One 6 2011 e20881
26. M. Lock Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material Hum. Gene Ther. 21 2010 1273 1285
27. A.M. Maguire Safety and efficacy of gene transfer for Leber's congenital amaurosis N. Engl. J. Med. 358 2008 2240 2248 (Pubitemid 351724453)
28. C.S. Manno AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B Blood 101 2003 2963 2972 (Pubitemid 36857981)
29. C.S. Manno Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response Nat. Med. 12 2006 342 347 (Pubitemid 43355084)
30. D.M. McCarty, H. Fu, P.E. Monahan, C.E. Toulson, P. Naik, and R.J. Samulski Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo Gene Ther. 10 2003 2112 2118 (Pubitemid 37536760)
31. J.R. Mendell Dystrophin immunity in Duchenne's muscular dystrophy N. Engl. J. Med. 363 2010 1429 1437
32. F. Mingozzi AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells Blood 114 2009 2077 2086
33. I. Mohiuddin, S. Loiler, I. Zolotukhin, B.J. Byrne, T.R. Flotte, and R.O. Snyder Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors Mol. Ther. 11 2005 320 326
34. P. Moullier, and R.O. Snyder International efforts for recombinant adeno-associated viral vector reference standards Mol. Ther. 16 2008 1185 1188 (Pubitemid 351866048)
35. H. Nakai, E. Montini, S. Fuess, T.A. Storm, M. Grompe, and M.A. Kay AAV serotype 2 vectors preferentially integrate into active genes in mice Nat. Genet. 34 2003 297 302 (Pubitemid 36792862)
36. M. Penaud-Budloo Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle J. Virol. 82 2008 7875 7885
37. K.P. Ponder Hemophilia gene therapy: A holy grail found Mol. Ther. 19 2011 427 428
38. M. Potter Manufacture and stability study of the recombinant adeno-associated virus serotype 2 vector reference standard Bioprocessing 7 2008 8 14
39. R.O. Snyder, and T.R. Flotte Production of clinical-grade recombinant adeno-associated virus vectors Curr. Opin. Biotechnol. 13 2002 418 423 (Pubitemid 35379925)
40. R.O. Snyder, X. Xiao, and R.J. Samulski Production of recombinant adeno-associated viral vectors N. Dracopoli, Current Protocols in Human Genetics 1996 John Wiley and Sons New York 12.11.11 12.11.24
41. H. Stedman, J.M. Wilson, R. Finke, A.L. Kleckner, and J. Mendell Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: Alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors Hum. Gene Ther. 11 2000 777 790 (Pubitemid 30180282)
42. X. Sun, Y. Lu, L.T. Bish, R. Calcedo, J.M. Wilson, and G. Gao Molecular analysis of vector genome structures after liver transduction by conventional and self-complementary adeno-associated viral serotype vectors in murine and nonhuman primate models Hum. Gene Ther. 21 2010 750 761
43. A. Toromanoff Safety and efficacy of regional intravenous (RI) versus intramuscular (IM) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle Mol. Ther. 16 2008 1291 1299 (Pubitemid 351866061)
44. M.R. Veldwijk Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks Mol. Ther. 6 2002 272 278 (Pubitemid 36336136)
45. J.A. Wagner Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus Laryngoscope 109 1999 266 274 (Pubitemid 29075570)
46. Z. Wang Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart Nat. Biotechnol. 23 2005 321 328 (Pubitemid 41094420)
47. A. Wistuba, A. Kern, S. Weger, D. Grimm, and J.A. Kleinschmidt Subcellular compartmentalization of adeno-associated virus type 2 assembly J. Virol. 71 1997 1341 1352 (Pubitemid 27030308)
48. Z. Zhen, Y. Espinoza, T. Bleu, J.M. Sommer, and J.F. Wright Infectious titer assay for adeno-associated virus vectors with sensitivity sufficient to detect single infectious events Hum. Gene Ther. 15 2004 709 715 (Pubitemid 38925223)